date:Feb 19, 2013
s and increased recognition of its benefits is, said Algatechnologies, driving the rapid rise in demand in the United States and Europe.
Grovepoint believes there is significant potential to grow the range of products where astaxanthin is the key ingredient and to fully exploit the potential of microalgae derived products for other commercial applications, said Leon Blitz, CEO at Grovepoint. Grovepoint will be making additional capital available for growing the existing business, marketing the